OSO BioPharmaceuticals Manufacturing Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • OSO BioPharmaceuticals Manufacturing's estimated annual revenue is currently $22.9M per year.(i)
  • OSO BioPharmaceuticals Manufacturing's estimated revenue per employee is $201,000

Employee Data

  • OSO BioPharmaceuticals Manufacturing has 114 Employees.(i)
  • OSO BioPharmaceuticals Manufacturing grew their employee count by -2% last year.

OSO BioPharmaceuticals Manufacturing's People

NameTitleEmail/Phone
1
Quality Assurance DirectorReveal Email/Phone
2
Validation ManagerReveal Email/Phone
3
IQA-PPTReveal Email/Phone
4
Sr. Tech, Quality SystemsReveal Email/Phone
5
Maintenance SupervisorReveal Email/Phone
6
Maintenace SupervisorReveal Email/Phone
7
Sr. PKG Technician/EngineeringReveal Email/Phone
8
Maunfacturing SupervisorReveal Email/Phone
9
SupervisorReveal Email/Phone
10
Filling TechnicianReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A2665-3%$200MN/A
Add Company

What Is OSO BioPharmaceuticals Manufacturing?

OsoBio was launched in May 2008, when a group of private investors acquired the Albuquerque, New Mexico, sterile injectables manufacturing business from Catalent Pharma Solutions. The company was renamed OSO BioPharmaceuticals Manufacturing, LLC. Prior to the acquisition, the business had a history of providing sterile injectable manufacturing services for almost 30 years. Built by Summa Medical in 1980, the company and facilities were later acquired by Erbamont and renamed Adria SP in 1988. In 1993, the business was acquired by Pharmacia and became Pharmacia-Upjohn in 1995. A management buyout in 1997 led to the company being renamed SP Pharmaceuticals, which then joined Cardinal Health’s Pharmaceutical Technologies and Services (PTS) Division. When Cardinal PTS was acquired by the Blackstone Group in 2007 and renamed Catalent, the Albuquerque business was offered for sale. In May 2008, the current investors purchased

keywords:N/A

N/A

Total Funding

114

Number of Employees

$22.9M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$37.7M116-2%N/A
#2
$16.5M1182%N/A
#3
$20.8M119-32%N/A
#4
$32.4M120-1%N/A
#5
$32.7M1211%N/A